Click here and follow the instructions! Once finished, place the sample in the hazard bag and return to your respective PIC (person-in-charge).

Pharmacogenomics (PGx), a core component in Precision Medicine, is the study of how genes affect a person’s response to medications. This field combines pharmacology (the science of drugs) and genomics (the study of genes and their functions) to develop effective, safe medications that can be prescribed based on a person’s genetic makeup while preventing medications’ side effects (known as Adverse Drug Reactions, ADRs). In other words, a medication can be safe for one but harmful for the other, even when prescribed with similar doses.

This test is open to the general public.
While there are no age restrictions for Pharmacogenomic (PGx) tests. For individuals below the age of 18, a legal guardian must complete the request and consent form. In the case of children, their phenotype (DNA traits) remains the same, but medication doses might change as they grow.

With an analytical accuracy and reliability of over 99%, our genome-wide platform has proven to be highly precise and dependable. The clinical recommendations in our report are accredited by the Health Science Authority (HSA) of Singapore – HSA Class A Medical Device, NQA (National Quality Assurance Limited) accredited by UKAS (United Kingdom Accreditation Service) for ISO13485 certified; while our laboratory operations strictly adhere to the standards set by CAP and ISO 15189.

ATCC, known as Advancing Tomorrow’s Cure Community, is a community established by Beacon Hospital to study how Asian genetics react to current medicines. To enjoy the sponsored pricing, it is REQUIRED to partake in the ATCC consent.

Your deidentified sample will be stored indefinitely as anonymous specimens for the option of being able to update your report at the minimal cost after the first FOC update with joining the ATCC, as well as for research purposes. Only an identification specimen number will be used, ensuring the anonymity and privacy of your data.
As for the possibility of research direction changes leading to activities related to cloning, Malaysia does not support human cloning therefore we will not be embarking on this area of research. Pharmacogenomics primarily focuses on understanding how an individual’s genetic makeup influences their response to drugs, optimising drug therapy based on genetic factors, and advancing personalized medicine. While research directions can evolve over time, the core focus of pharmacogenomics remains centered on drug response and genetic variability rather than cloning or genetic manipulation for other purposes.